JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (3): 51-53.doi: 10.6040/j.issn.1673-3770.0.2014.381

Previous Articles     Next Articles

Construction and identification of small interfering RNA targeting silence Trop2 expression in human laryngeal carcinoma cell line HEP2

CHEN Xiaoling1,2, FEI Bing1,3, LI Xianbin2, WU Hao1   

  1. 1. Department of Otolaryngology & Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China;
    2. Department of Otolaryngology, Zaoyang First People's Hospital, Zaoyang 441200, Hubei, China;
    3. Department of Otolaryngology, Jinhu People's Hospital, Jinhu 211600, Jiangsu, China
  • Received:2014-12-02 Revised:2015-04-03 Published:2015-06-16

PDF (PC)

414

Abstract: Objective To construct the small interfering RNA(siRNA) that can silence Trop2 expression and to investigate the silencing effect of siRNA on Trop2 gene in human laryngeal carcinoma cell line HEP2. Methods Three different gene sequences siRNA specific targeting Trop2 gene were constructed and used to transfect into HEP2 cells by using LipofectamineTM 2000. The negative control group and blank control group were set up at the same time. These cells were divided into the W group (un-transfection), the NC group (transfection with negative control), the T1 group(S1 sequence), the T2 group(S2 sequence) and the T3 group(S3 sequence). The transfection efficiency was reported by green fluorescence protein expression and gene inhibition efficiency was analyzed by real-time RT-PCR. Results Green fluorescence observed by fluorescence microscopy showed that siRNA had been transfected into HEP2 cells, and the transfection ratio was 90%. The expression levels of Trop2 mRNA in cells transfected with Trop2-specific siRNA were lower than those in the untransfected cells or cells transfected with negative control siRNA. Compared with the T2 and T3 groups, siRNA in the T1 group had the strongest inhibitory effect on the expression of Trop2 mRNA, and the difference was significant(0.470±0.063 vs 0.749±0.024, 0.824±0.027, P<0.05 ). Conclusion Effective siRNA sequence has been successfully constructed and selected which can inhibit the expression of Trop2 gene in human laryngeal carcinoma cell line HEP2. It is fundamental for the study on the function of Trop2 gene and the gene therapy of laryngeal carcinoma.

Key words: HEP2 cells, Laryngeal carcinoma, RNA interference, Trop2

CLC Number: 

  • R739.6
[1] RNA干扰:双链RNA引起的基因沉默机制—2006年诺贝尔生理学或医学奖成果简介[J]. 科技导报, 2006, 24 (12): 5-8.
[2] Elbashir S M, Lendeckel W, Tusch T. RNA interference is mediated by21 and 22 nucleotide RNAs[J]. Genes Dev, 2001, 15(2):188-200.
[3] Hunt K K, Vorburger S A. Hurdles and hopes for cancer treatment[J]. Science, 2002, 297(5580): 415-416.
[4] Fong D, Moser P, Krammel C, et al. High expression of Trop2 correlates with poor prognosis in pancreatic cancer[J]. Br J Cancer, 2008, 99(8):1290-1295.
[5] Fong D, Spizzo G, Gostner J M, et al. Trop2: a novel prognostic marker in squamous cell carcinoma of the oral cavity[J]. Mod Pathol, 2008, 21(2):186-191.
[6] Fang Y J, Lu Z H, Wang G Q, et al. Elevated expressions of MMP7, Trop2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer[J]. Int J Colorectal Dis, 2009, 24(8):875-884.
[7] Mühlmann G, Spizzo G, Gostner J, et al. Trop2 expression as prognostic marker for gastric carcinoma[J]. J Clin Pathol, 2009, 62(2):152-158.
[8] Bignotti E, Todeschini P, Calza S, et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients[J]. Eur J Cancer, 2010, 46(5):944-953.
[9] Coldren C D, Helfrich B A, Witta S E, et al. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines[J]. Mol Cancer Res, 2006, 4(8):521-528.
[10] Wang J, Day R, Dong Y, et al. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers[J]. Mol Cancer Ther, 2008, 7(2):280-285.
[11] Wu H, Xu H, Zhang S, et al. Potential therapeutic target and independent prognostic marker of Trop2 in laryngeal squamous cell carcinoma[J]. Head Neck, 2013, 35(10):1373-1378.
[12] 傅继梁.基因工程小鼠[M].上海:上海科学技术出版社, 2006:137-161.
[13] Grimm D. Small silencing RNAs: state-of-the-art[J]. Adv Drug Deliv Rev, 2009, 61(9):672-703.
[1] YE Shufeng, ZHANG Xu, SU Kai, LI Hejie, TENG Bo. Laryngocelesecondary to Laryngectomy:a case report and literature review [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 117-118.
[2] LI Guobin, ZHANG Zhancheng, WANG Xinyan. Up-regulation of miR-200b may inhibit epithelial mesenchymal transition process to prevent the proliferation, migration, and invasion of human laryngeal cancer Hep-2 cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 53-57.
[3] . Curcumin combined with resveratrol enhances their anti-tumoral effects in the head and neck carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 67-72.
[4] XU Yuanteng, CHEN Ruiqing, LIN Gongbiao, FANG Xiuling, YU Shujuan, LIANG Xiaohua, ZHANG Rong. Effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 110-114.
[5] LI Zewen, GUO Junyu, ZHOU Jie, YAN Fubo, YANG Zhimin, DING Zhuhua. Relationship between gastroesophageal reflux disease and laryngeal carcinoma: a meta-analysis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 40-46.
[6] LI Fu, ZHAO Shuyou. Expression of tumor suppressor in lung cancer 1 in laryngeal squamous cell carcinoma and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 36-38.
[7] LI Yingying, ZHOU Han, ZHANG Weiqiang, DONG Weida. Effects of silencing hypoxia inducible factor-1α on the expression of cytokines in cultured human nasal epithelial cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 38-42.
[8] PAN Chun-chen1, ZHANG Xiao-peng2, LAI Hai-chun3, WANG De-sheng3. Expression and  relationship of HMGA1 and Ezrin in laryngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(2): 27-31.
[9] ZOU Ji-dong, XU Wei, L Zheng-hua, CAO Hong-yuan. Correlation between maspin and p53 proteins in laryngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(6): 16-18.
[10] CHEN Jin-hui, TAO Ze-zhang. Expression and clinical significance of TERT and PCNA in the tissue and cell lines of laryngeal squamaous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(3): 5-8.
[11] Qian Xiaoyun1, Zhang Yifen2, Yu Chenjie1, Ding Xiaoqiong1, Qin Yang1, Qin Xiaoming1, Gao Xia1. Detection of micrometastasis in cervical lymph nodes from laryngeal or laryngopharyngeal carcinoma and preliminary research on the clinical significance of micrometastasis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(3): 9-14.
[12] GAO Chun-rong,YAN Yong-hong,CHAI Xiang-jun . Pathogens in sputum in laryngeal cancer patients after tracheotomy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(6): 498-499 .
[13] SUN Xin,JI Wen-yue . Long-term curative effect of the KTP laser for laryngeal carcin [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(5): 393-395 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd